Recist 1.0 Vs 1.1 App - Recist 1.0 Vs 1.1 for iPad & Reviews

BioClinica's "Interactive RECIST Training Program" is an excellent learning technique that will guide the user through the criteria and its classifications on response for solid tumors.
RECIST (Response Evaluation Criteria in Solid Tumors) was originally published in 2000 as version 1.0. An update 1.1 was released in January 2009 by an international collaborative group involved in cancer research. Numerous clinical trials, both past and present, use these criteria to evaluate solid tumor response in the drug development process.
It will describe the major differences between the RECIST versions 1.0 and 1.1.